scientific-updates-amidst-the-pandemic:-edition-32-from-voice-for-science-and-solidarityScientific Updates Amidst the Pandemic: Edition 32 from Voice for Science and Solidarity
voice-for-science-and-solidarity:-vss-scientific-updates-in-the-era-of-pandemic-#33Voice for Science and Solidarity: VSS Scientific Updates in the Era of Pandemic #33
vaccinating-children-against-sars-cov-2-is-not-justified-by-mis-c,-says-voice-for-science-and-solidarity

Vaccinating children against SARS-CoV-2 is not justified by MIS-C, says Voice for Science and Solidarity

Published On: 14. Mai 2023 12:41

Introduction

The COVID-19 pandemic has affected millions of people worldwide, and children have not been spared. Although children are less likely to develop severe COVID-19, they can still contract the virus and develop complications such as Multisystem Inflammatory Syndrome in Children (MIS-C). MIS-C is a rare but serious condition that can cause inflammation in various parts of the body, including the heart, lungs, kidneys, brain, skin, eyes, and gastrointestinal organs.

Recently, there has been a debate about whether children should be vaccinated against SARS-CoV-2, the virus that causes COVID-19, to prevent MIS-C. Some experts argue that vaccinating children could reduce the risk of MIS-C, while others believe that the risk of MIS-C is not a sufficient reason to vaccinate children. In this article, we will explore both sides of the argument and provide our perspective on the issue.

The Argument for Vaccinating Children

Proponents of vaccinating children against SARS-CoV-2 argue that it could reduce the risk of MIS-C, which is a serious and potentially life-threatening condition. They point to studies that have shown a link between COVID-19 and MIS-C, with some estimates suggesting that up to 2% of children who contract COVID-19 may develop MIS-C.

Furthermore, they argue that vaccinating children could help to reduce the spread of the virus and protect vulnerable populations, such as the elderly and those with underlying health conditions. Children can be asymptomatic carriers of the virus, which means that they can spread it to others without showing any symptoms. By vaccinating children, we can reduce the overall spread of the virus and protect those who are at higher risk of developing severe COVID-19.

The Argument Against Vaccinating Children

Opponents of vaccinating children against SARS-CoV-2 argue that the risk of MIS-C is not a sufficient reason to vaccinate children. They point out that MIS-C is a rare condition, and most children who contract COVID-19 do not develop it. They also argue that the long-term effects of the vaccine on children are unknown, and that we should not rush to vaccinate them without more data.

Furthermore, they argue that children are at low risk of developing severe COVID-19, and that the focus should be on vaccinating those who are at higher risk, such as the elderly and those with underlying health conditions. They also point out that vaccinating children could divert resources away from other important public health measures, such as testing, contact tracing, and treatment.

Conclusion

In conclusion, the debate about whether to vaccinate children against SARS-CoV-2 is complex, and there are valid arguments on both sides. While MIS-C is a serious condition, it is also rare, and most children who contract COVID-19 do not develop it. Furthermore, the long-term effects of the vaccine on children are unknown, and we should proceed with caution before vaccinating them.

At the same time, we cannot ignore the fact that children can contract and spread the virus, and that vaccinating them could help to reduce the overall spread of the virus and protect vulnerable populations. Ultimately, the decision to vaccinate children against SARS-CoV-2 should be based on a careful consideration of the risks and benefits, and should take into account the latest scientific evidence and public health guidance

Original article Teaser

MIS-C in children does NOT justify (at all!) their vaccination against SARS-CoV-2 | Voice for Science and Solidarity

Multisystem inflammatory syndrome in children (MIS-C) does NOT justify (at all!) their vaccination against SARS-CoV-2MIS-C is a disease that may occur in school-age children two to six weeks after infection with SARS-CoV-2 (SC-2) virus. MIS-C is a post-infectious inflammatory condition which typically occurs after asymptomatic/mild SC-2 infection. Some children may need hospitalization because of inflammatory reactions in different organs. While the syndrome can be serious, the absolute risk for MIS-C is very low (about 6.5 per 100 000 person-years) and known to be increased in boys aged 5-11 years with foreign-born parents, asthma, obesity, and life-limiting condition (https://www.thelancet.com/action/showPdf?pii=S2666-7762%2822%2900137-5).  MIS-C mostly resolves within a few days after timely and adequate (immunosuppressive) treatment. As the pandemic evolves and more infectious Omicron (sub)variants

Details to MIS-C in children does NOT justify (at all!) their vaccination against SARS-CoV-2 | Voice for Science and Solidarity

Categories: Quellen, The CradleTags: Daily Views: 1Total Views: 13
scientific-updates-amidst-the-pandemic:-edition-32-from-voice-for-science-and-solidarityScientific Updates Amidst the Pandemic: Edition 32 from Voice for Science and Solidarity
voice-for-science-and-solidarity:-vss-scientific-updates-in-the-era-of-pandemic-#33Voice for Science and Solidarity: VSS Scientific Updates in the Era of Pandemic #33